Tandem Michael addition/amino-nitrile cyclization from 2-formyl-1,4-DHP in the synthesis of novel dihydroindolizine-based compounds

Journal of Organic Chemistry

Volumn 71, Issue 24, 2006, Pages 9114-9127

  Marchalín, Štefan ^a   Baumlová, Barbora ^a   Baran, Peter ^b   Oulyadi, Hassan ^c   Daïch, Adam ^d  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b JUNIATA COLLEGE   (United States)

^c UNIVERSITÉ DE ROUEN   (France)

^d UNIVERSITÉ DU HAVRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN COMPOUNDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SATURATION (MATERIALS COMPOSITION); SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL); X RAY DIFFRACTION ANALYSIS;

DIHYDROINDOLIZINE; MALONONITRILE;

AROMATIC COMPOUNDS;

ACETOACETIC ACID; ALKYL GROUP; AMINE; BASE; CARBENE; COPPER CHLORIDE; DIHYDROPYRIDINE DERIVATIVE; HETEROCYCLIC COMPOUND; INDOLIZINE DERIVATIVE; KETONE DERIVATIVE; MALONONITRILE; NITRILE; NITROUS ACID; ORGANIC COMPOUND; PYRIDINE DERIVATIVE; REAGENT; SULFINIC ACID DERIVATIVE; VINYL DERIVATIVE;

ARTICLE; BIOTRANSFORMATION; CATALYSIS; CIS ISOMER; CYCLIZATION; DIASTEREOISOMER; EPIMERIZATION; HYDROGENATION; KNOEVENAGEL CONDENSATION; MICHAEL ADDITION; MOLECULAR STABILITY; NUCLEAR MAGNETIC RESONANCE; OXIDATION; QUANTUM YIELD; REACTION ANALYSIS; ROOM TEMPERATURE; SOLID STATE; STEREOCHEMISTRY; SYNTHESIS; TECHNIQUE; THERMODYNAMICS; X RAY DIFFRACTION;

AMINES; CYCLIZATION; FORMALDEHYDE; INDOLIZINES; KINETICS; MASS SPECTROMETRY; NITRILES; PYRANS; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 33845190463     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0615044     Document Type: Article

References (75)

1. For recent reviews of synthesis and biological activity, see: (a) Nemr, A. E. Tetrahedron 2000, 56, 8579.
2. (b) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 2000, 11, 1645.
3. (c) Sears, P.; Wong, C.-H. Angew. Chem., Int. Ed. 1999, 38, 2300.
4. (d) Michael, J. P. Nat. Prod. Rep. 1999, 16, 675.
5. (e) Elbein, A. D.; Molyneux, R. J. In Iminosugars as Glycosidase Inhibitors; Stutz, A. E., Ed.; Wiley-VCH: Weinheim, Germany, 1999; p 216.
6. (f) Michael, J. P. Nat. Prod. Rep. 1997, 14, 619.
7. (g) Takahata, H.; Momose, T. In The Alkaloids; Cordell, G. A., Ed.; Academic: San Diego, CA, 1993; Vol. 44, Chapter 3.
8. (h) Elbein, A. D.; Molyneux, R. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Wiley and Sons: New York, 1987; Vol. 5.
9. Two alkaloids containing an indolizine nucleus within a fused ring system have been reported: Flitsch, W. In Comprehensive Heterocyclic Chemistry; Katritzky, A. R., Ress, C. W., Eds.; Pergamon: Oxford, 1984; Vol. 4, p 476.
10. (a) Pla, D.; Marchal, A.; Olsen, C. A.; Albericio, F.; Alvarez, M. J. Org. Chem. 2005, 70, 8231.
11. (b) Marco, E.; Laine, W.; Tardy, C.; Lansiaux, A.; Iwao, M.; Ishibashi, F.; Bailly, C.; Gago, F. J. Med. Chem. 2005, 48, 3796.
12. (c) Pla, D.; Marchal, A.; Olsen, C. A.; Francesch, A.; Cuevas, C.; Albericio, F.; Alvarez, M. J. Med. Chem. 2006, 49, 3257 and references therein.
13. Kel'in, A. V.; Sromek, A. W.; Gevorgyan, V. J. Am. Chem. Soc. 2001, 123, 2074.
14. Numerous polysubstituted indolizines have been patented. See: (a) James, D.; Chimmanamada, D.; Sun, L.; Koya, K.; Przewloka, T.; Ono, M.; Nagai, M. Canadian Patent, CA 2,509,214, 2004.
15. (b) Koya, K.; Sun, L.; Xia, Z. Q.; Zhang, S.; Przewloka, T. Canadian Patent, CA 2,596,764, 2004.
16. (a) Yue, G.; Wan, Y.; Song, S.; Yang, G.; Chen, Z. Bioorg. Med. Chem. Lett. 2005, 15, 453.
17. (b) Weide, T.; Arve, L.; Prinz, H.; Waldmann, H.; Kessler, H. Bioorg. Med. Chem. Lett. 2006, 16, 59.
18. (a) Rotaru, A. V.; Druta, I. D.; Oeser, T.; Müller, T. J. J. Helv. Chem. Acta 2005, 88, 1798.
19. (b) Delattre, F.; Woisel, P.; Surpateanu, G.; Cazier, F.; Blach, P. Tetrahedron 2005, 61, 3939.
20. For a recent contribution in this area. see: Jaung, J. Y.; Jung, Y. S. Bull. Korean Chem. Soc. 2003, 24, 1565.
21. Hu, J.; Jiang, X.; He, T.; Zhou, J.; Hu, Y.; Hu, H. J. Chem. Soc., Perkin Trans. 1 2001, 1820.
22. Sonnenschein, H.; Kreher, T.; Grundemann, E.; Kruger, R. P.; Kunath, A.; Zabel, V. J. Org. Chem. 1996, 61, 710.
23. Gravestock, D.; Peirson, I. G. Tetrahedron Lett. 2000, 41, 3497 and references therein.
24. Dragovich, P. S.; Zhou, R.; Prins, T. J. J. Org. Chem. 2002, 67, 741 and references therein.
25. (a) Mori, M.; Hori, M.; Sato, Y. J. Org. Chem. 1998, 63, 4832.
26. (b) Settambolo, R.; Guazzelli, G.; Mengali, L.; Mandoli, A.; Lazzaroni, R. Tetrahedron: Asymmetry 2003, 14, 2491.
27. (c) Settambolo, R.; Guazzelli, G.; Mandoli, A.; Lazzaroni, R. Tetrahedron: Asymmetry 2004, 15, 1821.
28. Anderson, R. J.; Raolji, G. B.; Kanazawa, A.; Greene, A. E. Org. Lett. 2005, 7, 2989.
29. Bhattacharya, G.; Su, T. L.; Chia, C. M.; Chen. K. T. J. J. Org. Chem. 2001, 66, 426.
30. For representative reviews in this area, see: (a) Dürr, H. Pure Appl. Chem. 1990, 62, 1477.
31. (b) Alfimov, M. V.; Fedorova, O. A.; Gromov, S. P. J. Photochem. Photobiol. A; Chem. 2003, 158, 183.
32. (c) Minkin, V. I. Chem. Rev. 2004, 104, 2751.
33. For interesting and rare pharmaceutical applications of dihydroindolizines, see: (a) Rosseels, G.; Inion, H. United Kingdom Patent Appl. GB 2,064,536, 1980.
34. For representative syntheses of indolizines, see: (a) Bora, U.; Saikia, A.; Boruah, R. C. Org. Lett. 2003, 5, 435.
35. (b) Tielmann, P.; Hoenke, C. Tetrahedron Lett. 2006, 47, 261 and references therein.
36. (a) Scholtz, M. Ber. Dtsch. Chem. Ges. 1912, 45, 734.
37. (b) Boekelheide, V.; Windgassen, R. J., Jr. J. Am. Chem. Soc. 1959, 81, 1456.
38. (a) Tschitschibabin, A. E. Ber. Dtsch. Chem. Ges. 1927, 60, 1606.
39. (b) Hurst, J.; Melton, T.; Wibberley, D. G. J. Chem. Soc. 1965, 2948.
40. (c) Jones, G.; Stanyer, J. J. Chem. Soc. C 1969, 901.
41. Kaloko, J., Jr.; Hayford, A. Org. Lett. 2005, 7, 4305 and references therein.
42. Marchalín, Š.; Cvopová, K.; Križ, M.; Baran, P.; Oulyadi, H.; Daïch, A. J. Org. Chem. 2004, 69, 4227.
43. Chudík, M.; Marchalín, Š.; Knesl, P.; Daïch, A.; Decroix, B. J. Heterocycl. Chem. 2000, 37, 1549.
44. Chudík, M.; Marchalín, Š.; Daïch, A.; Decroix, B. Res. Adv. Synth. Org. Chem. 2000, 1, 1.
45. (a) Chudík, M.; Marchalín, Š.; Havrilová, K. Collect. Czech. Chem. Commun. 1998, 63, 826.
46. (b) Chudík, M.; Marchalín, Š.; Pham-Huu, D.-P.; Humpa, O.; Friedl, Z. Monatsh. Chem. 1999, 130, 1241.
47. (c) Marchalín, Š.; Chudík, M.; Cvopová, K.; Kožíšek, J.; Leško, J.; Daïch, A. Tetrahedron 2002, 58, 5747.
48. Marchalín, Š.; Cvopová, K.; Pham-Huu, D.-P.; Chudík, M.; Kožíšek, J.; Svoboda, I.; Daïch, A. Tetrahedron Lett. 2001, 42, 5663.
49. For X-ray single-crystal structure determination of (±)-16a, see Supporting Information.
50. For reviews, see: (a) Bossert, F.; Vater, W. Med. Res. Rev. 1989, 9, 291.
51. (b) Goldmann, S.; Stoltefuss, J. Angew. Chem., Int. Ed. Engl. 1991, 30, 1559 and references therein.
52. (c) Marchalín, Š.; Chudík, M.; Mastihuba, V.; Decroix, B. Heterocycles 1998, 48, 1943 and references therein.
53. (a) Marchalín, Š.; Ilavský, D.; Bruncko, M. Monatsh. Chem. 1989, 120, 1101.
54. (b) For a review in this field, see: Kuthan, J.; Sebek, P.; Böhm, S. Adv. Heterocycl. Chem. 1995, 62, 19.
55. For recent contributions in this area, see: (c) Kemnitzer, W.; Drewe, J.; Jiang, S.; Zhang, H.; Wang, Y.; Zhao, J.; Jia, S.; Herich, J.; Labreque, D.; Storer, R.; Meerovitch, K.; Bouffard, D.; Rej, R.; Denis, R.; Blais, C.; Lamothe, S.; Attardo, G.; Gourdeau, H.; Tseng, B.; Kasibhatla, S.; Cai, S. X. J. Med. Chem. 2004, 47, 6299.
56. (d) Kaupp, G.; Naimi-Jamal, M. R.; Schmeyers, J. Tetrahedron 2003, 59, 3753.
57. (a) Hess, B. A., Jr.; Schaad, L. J.; Pancir, J. J. Am. Chem. Soc. 1985, 107, 149.
58. (b) Jensen, F. J. Am. Chem. Soc. 1995, 117, 7487.
59. (c) Hussénius, A.; Matsson, O.; Bergson, G. J. Chem. Soc., Chem. Commun. 1998, 107, 2693.
60. (d) Okajima, T.; Imafuku, K. J. Org. Chem. 2002, 67, 625.
61. (e) Hudson, C. E.; McAdoo, D. J. J. Org. Chem. 2003, 68, 2735.
62. For a review for oxidations of DHP with metals, see: Han, B.; Liu, Z.; Liu, Q.; Zang, L.; Liu, Z.-L.; Yu, W. Tetrahedron 2006, 62, 2492 and citations therein.
63. For X-ray single-crystal structure determination of (1R*,7R̈ *,1′S*)-22b, see crystallographic characteristics in Supporting Information.
64. For X-ray single-crystal structure determination of 26bA, see Supporting Information.
65. For X-ray single-crystal structure determination of (1R*,7R̈ *,1′S*)-27, see crystallographic characteristics in Supporting Information.
66. (a) DePuy, C. H.; King, R. W. Chem. Rev. 1960, 60, 431.
67. (b) Kotani, R.; Satoh, S. J. Org. Chem. 1965, 30, 3245.
68. (c) Adam, W.; Arce, J. J. Org. Chem. 1972, 37, 507.
69. Quast, H.; Dietz, T. Synthesis 1995, 1300.
70. (a) Elson, K. E.; Jenkins, I. D.; Loughlin, W. A. Org. Biomol. Chem. 2003, 1, 2958.
71. (b) Hendrickson, J. B. In Encyclopaedia of Reagents for Organic Synthesis; Paquette, L. A., Ed.; Wiley: 1995; Vol. 8. pp 5405-5407.
72. (c) Hendrickson, J. B.; Schwartzman, S. M. Tetrahedron Lett 1975, 277.
73. For examples of nitrous acid elimination, see: (a) Danishefsky, S.; Prisbylla, M. P.; Hiner, S. J. Am. Chem. Soc. 1978, 100, 2918.
74. (b) Ono, N.; Miyake, H.; Tanikaga, R.; Kaji, A. J. Org. Chem. 1982, 47, 5017.
75. (c) Bernasconi, C. F.; Montanez, R. L. J. Org. Chem. 1997, 62, 8162.